Yuki Noguchi

Updated June 22, 2026 at 10:46 AM EDT Blood tests on the horizon, and under federal regulatory view, may be about to transform cancer care — and survival. The Food and Drug Administration has been evaluating a blood test called Galleri (pronounced like "g... See more

Blood tests on the horizon, and under federal regulatory view, may be about to transform cancer care — and survival. The Food and Drug Administration has been evaluating a blood test called Galleri (pronounced like "gallery") as a breakthrough device that... See more

GLP-1 medications are sold under several different brand names and treat diabetes, obesity and sleep apnea. The drugs' effects on cancer are in very early stages of research. Michael Siluk/Universal Images Group via Getty Images hide caption toggle captio... See more

There is mounting evidence to suggest GLP-1 obesity treatments also help reduce cancer risk, according to several recent studies. The studies are correlative, but appear to show the drugs not only reverse the carcinogenic risks that come with obesity, the... See more

AILSA CHANG, HOST: There's mounting evidence suggesting that GLP-1 drugs also help reduce cancer risk. NPR's Yuki Noguchi reports that several recent studies find a strong correlation, but now the question is - why? YUKI NOGUCHI, BYLINE: GLP-1 drugs act o... See more